Research output per year
Research output per year
Fingerprint
Dive into the research topics where Neil Rayment is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 5 Article
-
THE MORPHOLOGICAL ANALYSIS OF CRYSTALLINE METHADONE: A NOVEL COMBINATION OF MICROSCOPY TECHNIQUES
Al-Hasani, N. R., Royall, P. G., Rayment, N. & Wolff, K., 2022, In: ScienceRise: Pharmaceutical Science. 2022, 4, p. 44-52 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Defective macrophage handling of Escherichia coli in Crohn's disease
Elliott, T. R., Hudspith, B. N., Rayment, N. B., Prescott, N. J., Petrovska, L., Hermon-Taylor, J., Brostoff, J., Boussioutas, A., Mathew, C. G. & Sanderson, J. D., 2015, In: Journal of Gastroenterology and Hepatology.Research output: Contribution to journal › Article › peer-review
25 Citations (Scopus) -
Lamina propria macrophage phenotypes in relation to Escherichia coli in Crohn's disease
Elliott, T. R., Rayment, N. B., Hudspith, B., Hands, R. E., Taylor, K., Parkes, G. C., Prescott, N. J., Petrovska, L., Hermon-Taylor, J., Brostoff, J., Boussioutas, A., Mathew, C. G., Bustin, S. A. & Sanderson, J. D., 3 Jul 2015, In: BMC GASTROENTEROLOGY. 15, 75.Research output: Contribution to journal › Article › peer-review
13 Citations (Scopus) -
Quantification and Characterization of Mucosa-Associated and Intracellular Escherichia coli in Inflammatory Bowel Disease
Elliott, T. R., Hudspith, B. N., Wu, G., Cooley, M., Parkes, G., Quinones, B., Randall, L., Mandrell, R. E., Fagerquist, C. K., Brostoff, J., Rayment, N. B., Boussioutas, A., Petrovska, L. & Sanderson, J., Oct 2013, In: Inflammatory Bowel Diseases. 19, 11, p. 2326-2338 13 p.Research output: Contribution to journal › Article › peer-review
35 Citations (Scopus) -
Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease
Lindsay, J. O., Whelan, K., Stagg, A. J., Gobin, P., Al-Hassi, H. O., Rayment, N., Kamm, M. A., Knight, S. C. & Forbes, A., 14 Sept 2006, In: Gut. 55, 3, p. 348-355 8 p.Research output: Contribution to journal › Article › peer-review
361 Citations (Scopus)